Adverse events · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients on HD with HCV infection
Standard interferon showed no clear difference in adverse events compared with placebo or control (moderate certainty).
1 finding from 1 review
Death · patients on HD with HCV infection
Pegylated interferon alpha‐2a showed no clear difference in death compared with standard interferon (low certainty).
1 finding from 1 review
Relapse Number of participants having recurrence after stopping · patients on HD with HCV infection
Pegylated interferon alpha‐2a showed no clear difference in relapse(recurrence after stopping) compared with standard interferon (low certainty).
1 finding from 1 review
End‐of‐treatment response · patients on HD with HCV infection
Pegylated interferon alpha‐2a may leads to higher end‐of‐treatment response compared with standard interferon (low certainty).
1 finding from 1 review
Use of physical restraints · older people in all long‐term care settings
1 finding from 1 review
Serious adverse events related to the use of physical restraints ‐ not measured · older people in all long‐term care settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of physical restraint use ‐ not measured · older people in all long‐term care settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Falls · older people in all long‐term care settings
1 finding from 1 review
Fall‐related injuries ‐ not measured · older people in all long‐term care settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Residents with at least one psychotropic medication ‐ not measured · older people in all long‐term care settings
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants sustaining recurrent patellar dislocation · people with lateral patellar dislocation
It is very uncertain whether surgical changes number of participants sustaining recurrent patellar dislocationa compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Kujala patellofemoral disorders score Scale from: 0 to 100 (higher scores = better function) · people with lateral patellar dislocation
It is very uncertain whether surgical changes knee and physical functiona Measured using the Kujala patellofemoral… compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Adverse effects of treatment Overall incidence of complications · people with lateral patellar dislocation
It is very uncertain whether surgical changes adverse effects of treatment Overall incidence of complications compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Patient satisfactiona Reported as 'good' or 'excellent'. · people with lateral patellar dislocation
It is very uncertain whether surgical changes patient satisfactiona Reported as 'good' or 'excellent'. compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Patient‐reported knee instabilitya Incidence of patellar subluxation · people with lateral patellar dislocation
It is very uncertain whether surgical changes patient‐reported knee instabilitya Incidence of patellar subluxation compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Subsequent requirement for surgery (re‐operations) for complications Incidence · people with lateral patellar dislocation
It is very uncertain whether surgical changes subsequent requirement for surgery (reoperations) for complicationsa… compared with non‐surgical treatment (very low certainty).
1 finding from 1 review
Proportion of children who received DTP3 or Penta 3 by 1 year of age · children under 5 years of age
Health education may leads to higher proportion of children who received DTP3/Penta 3 by 1 year of age compared with routine care (low certainty).
1 finding from 1 review
Occurrence of vaccine‐preventable diseases · children under 5 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who received the vaccine under study (measles) · children under 5 years of age
Engagement of community leaders probably leads to higher proportion of children who received the vaccine under study (measles) compared with routine care (moderate certainty).
1 finding from 1 review